<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/257323-prolonged-release-compositions-comprising-torasemide-and-a-matrix-forming-polymer by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:34:58 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 257323:PROLONGED-RELEASE COMPOSITIONS COMPRISING TORASEMIDE AND A MATRIX-FORMING POLYMER</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PROLONGED-RELEASE COMPOSITIONS COMPRISING TORASEMIDE AND A MATRIX-FORMING POLYMER</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The invention discloses a Prolonged-release composition comprising torasemide as active ingredient, a matrix-forming polymer, wherein the matrix forming polymer is guar gum and is present in a proportion of from 1 to 40% of said composition, and lactose as a diluent.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br>
Field of the invention<br>
This invention relates to prolonged-release diuretic<br>
compositions containing torasemide as active ingredient.<br>
Brief description of the accompanying drawings<br>
Figure 1 shows the curves of in-vitro release	rate<br>
(cumulative values) of torasemide comparatively	for<br>
immediate-release (IR) tablets and prolonged-release	(PR)<br>
tablets according to Example 8.<br>
Figure 2 shows the curves of in-vitro release rate of<br>
torasemide comparatively for immediate-release (IR)<br>
tablets and prolonged-release (PR) tablets according to<br>
Example 8.<br>
Figure 3 shows the plasma concentration curves in man<br>
after administration of torasemide comparatively for<br>
immediate-release (IR) tablets and prolonged-release (PR)<br>
tablets according to Example 8.<br>
Figure 4 shows the versus-time curves of the number of<br>
urinary urgencies in man after administration of<br>
torasemide comparatively for immediate-release (IR)<br>
tablets and prolonged-release (PR) tablets according to<br>
Example 8.<br>
Figure 5 shows release profiles (with HC1 0.1N) of<br>
Torasemide from Meyprogat® 90 matrix tablets.<br>
Background of the invention<br>
Torasemide (US 4018929) is a potent diuretic with an<br>
extensive clinical use. Torasemide mainly acts by<br>
inhibiting sodium reabsorption in the ascending limb of<br><br>
Henle's loop (Puschett JB and Jordan LL. Mode of action<br>
of Torasemide in man. Progress in Pharmacology and<br>
Clinical Pharmacology. 1990;8(1):7-13). Torasemide<br>
interferes with Na+2C1-K+ pump in the luminal cell<br>
membrane and blocks the basolateral chloride conductance<br>
(Greger R. Inhibition of active NaCl reabsortion in the<br>
thick ascending limb of the loop of Henle by torasemide.<br>
Arzneim Forsch./Drug Res. 1988;38{1):151-155).<br>
The bioavailability for torasemide is 80-90% after oral<br>
administration, the kinetics is linear and the<br>
elimination half-life is 3-4 hours. The pharmacokinetic<br>
profile is characterized by a peak of maximum plasma<br>
concentration (Cmax) which is reached within a rather<br>
short period of time {tmax: approximately 1 hour) and by a<br>
rapid elimination (t4: approximately 3-4 hours)<br>
(Neugebauer G, Besenfelder E and Mollendorf E.<br>
Pharmacokinetics and metabolism of torasemide in man.<br>
Arzneim Forsch./Drug Res. 1988;38 (1):164-166). Torasemide<br>
shows a, linear dose-response relationship at doses, from<br>
2.5 to 20 mg for urinary volume. The sodium excretion<br>
exerts a minimal effect on potassium. (Scheen AJ. Dose-<br>
response curve of torasemide in healthy volunteers.<br>
Arzneim Forsch./Drug Res. 1988/38 (1):156-159; Barr WH et<br>
al. Torasemide dose-proportionality of pharmacokinetics<br>
and pharmacodynamics. Progress in Pharmacology and<br>
Clinical Pharmacology. 1990;8(1):29-37). The maximal<br>
effects on urine and electrolytes excretions are observed<br>
at approximately 2 hours after oral administration (Lesne<br>
M. Comparison of the pharmacokinetics and<br>
pharmacodynamics of torasemide and furosemide in healthy<br>
volunteers. Arzneim Forsch./Drug Res. 1988;38(1):160-<br>
163) . All these effects clinically become apparent as an<br>
acute diuresis and by episodes of urinary urgency and<br>
suprapubic discomfort (Lambe R, Kennedy 0, Kenny M and<br><br>
Darragh A. Study of tolerance and diuretic properties of<br>
torasemide following oral or intravenous administration<br>
to healthy volunteers. Eur J Clin Pharmacol<br>
1986;31(Suppl):9-14).<br>
Therefore, the availability of torasemide compositions,<br>
which may avoid the troublesome urinary urgencies caused<br>
by conventional immediate-release compositions is of a<br>
great interest.<br>
Summary of the invention.<br>
An object of the present invention is to prepare diuretic<br>
compositions that may provide more stable plasma levels<br>
of torasemide in order to avoid the initial peak. This<br>
will provide a kinetic profile with fewer fluctuations<br>
and steadier levels. Thus, the frequency of urinary<br>
urgencies is reduced, which results in a greater comfort<br>
for patients who need treatment with torasemide.<br>
The compositions of the present invention comprise<br>
torasemide, as active ingredient, and an excipient chosen<br>
from matrix-forming polymers, for example, polymers of<br>
acrylic acid, cellulose, glycerol behenate, guar gum,<br>
xanthan gum, chitosan, gelatin, polyvinyl alcohol and the<br>
like. In each composition one only polymer or a mixture<br>
thereof may be used. Other components that complete the<br>
compositions of the present invention are the usual<br>
excipients in pharmaceutical technology comprising<br>
diluents, for example, lactose, cellulose, mannitol,<br>
calcium phosphate and the like, as well as the mixtures<br>
thereof; binding- and disintegrating-action agents, for<br>
example, Aerosil® 200, starch, and the like, as well as<br>
the mixtures thereof; lubricants, for example, magnesium<br>
stearate, talc, and the like, as well as the mixtures<br><br>
thereof. Generally, the compositions of the present<br>
invention contain the active ingredient in a proportion<br>
from 0.5 to 20%, and the matrix-forming polymer in a<br>
proportion from 1 to 40%.<br>
The compositions of the present invention are tablets for<br>
oral administration.<br>
The compositions of the present invention maintain<br>
diuresis over a maximal period of 24 hours, preferably<br>
within the first 12 hours; thus, the possible disturbance<br>
of nocturnal enuresis is avoided. As the Cmax of plasma<br>
levels attained after administration is minimal, the<br>
troublesome urinary urgency induced by immediate-release<br>
compositions is prevented.<br>
Detailed description of the invention<br>
The tablets of the present invention contain the active<br>
ingredient, torasemide, in an amount of 0.5 to 20 mg. In<br>
practice, doses of 5, 10 and 20 mg per tablet are<br>
preferred. The matrix-forming polymers are chosen from<br>
the following groups: 1) acrylic polymers, for example,<br>
Carbopol® (a carbomer -a polymer of acrylic acid polymer),<br>
Kollicoat® (a copolymer of methacrylic acid), and their<br>
analogues and derivatives; 2) cellulose polymers, for<br>
example Methocel® (hydroxypropylmethylcellulose),<br>
methylcellulose, sodium carboxymethylcellulose, Natrosol®<br>
(hydroxyethylcellulose) and their analogues and<br>
derivatives; 3) Compritol® (glyceryl behenate); 4)<br>
Meyprogat® (guar gum) and its analogues and derivatives;<br>
5) xanthan gum; 6) chitosan; 7) gelatin; and 8) polyvinyl<br>
alcohol and its derivatives.<br><br>
The compositions of the present invention contain the<br>
active ingredient, torasemide, in a proportion from 0.5<br>
to 20% and the matrix-forming polymer in a proportion<br>
from 1 to 40%. The most convenient matrix-forming polymer<br>
was found to be guar gum, preferably in a proportion of<br>
4%. However, other matrix-forming polymers may be<br>
employed in the compositions; their proportions may be<br>
varied within a relatively wide range. Thus, Carbopol® is<br>
formulated at concentrations from 1 to 20%, preferably<br>
10%, Methocel® at concentrations from 1 to 50%, preferably<br>
40%, Natrosol® and Compritol® at concentrations from 1 to<br>
40%, preferably 20%, Kolllcoat* at concentrations from 1<br>
to 40%, preferably 15% and Meyprogat® at concentrations<br>
from 1 to 40%, preferably 4%.<br>
The tablets of the present invention are manufactured<br>
according to standard procedures of pharmaceutical<br>
technology by direct compression or by wet granulation in<br>
such a way that moisture of the resulting dry granulate<br>
is lower than 10 %.<br>
An in vitro dissolution test is performed on the tablets<br>
of the present invention using apparatus 2/paddle<br>
stirring element (according to U.S. Pharmacopeia) at 50<br>
rpm.<br>
In order to obtain a dissolution profile that fully<br>
models the physiological conditions, the test is<br>
performed within the first 2 hours at pH 1 and thereafter<br>
at pH 6.8. The results obtained are presented in Figures<br>
1 and 2. Fig. 1 shows torasemide release (cumulative<br>
values) and Fig. 2 shows torasemide release.<br>
The present invention is further illustrated by - but not<br>
limited to - the following examples.<br><br>
Example 1: 5 mg tablets	of torasemide with Carbopol® and a<br>
total weight of 85 mg<br>
Torasemide	5.0 mg<br>
Carbopol 940®	10.0 mg<br>
Lactose	48.0 mg<br>
Magnesium stearate	0.3 mg<br>
Aerosil® 200	0.5 mg<br>
Mannitol q.s.	85 mg<br>
Example 2: 5 mg tablets	of torasemide with Methocel® and a<br>
total weight of 100 mg<br>
Torasemide	5.0 mg<br>
Methocel K 15 M*	40.0 mg<br>
Lactose	18.0 mg<br>
Corn starch	36.2 mg<br>
Pregelatinized starch	0.3 mg<br>
Aerosil® 200	0.5 mg<br>
Example 3: 5 mg tablets	of torasemide with Natrosol® and a<br>
total weight of 85 mg<br>
Torasemide	5.0 mg<br>
Natrosol HX®	20.0 mg<br>
Magnesium stearate	0.3 mg<br>
Aerosil® 200	0.5 mg<br>
Microcrystalline cellulose q.s. 85 mg<br>
Example 4: 5 mg tablets of torasemide with Compritol® and<br>
a total weight of 100 mg<br>
Torasemide	5.0 mg<br><br>
Compritol 888®	20.0 mg<br>
Lactose	38.0 mg<br>
Corn starch	36.2 mg<br>
Magnesium stearate	0.3 mg<br>
Talc	0.5 mg<br>
Example 5: 10 mg tablets of torasemide with Kollicoat® and<br>
a total weight of 85 mg<br>
Torasemide	10.0 mg<br>
Kollicoat® SR 30 D	30.0 mg<br>
Magnesium stearate	0.6 mg<br>
Talc	1.0 mg<br>
Calcium phosphate q.s.	85 mg<br>
Example 6: 5 mg tablets of torasemide with Meyprogat® and<br>
a total weight of 100 mg<br>
Torasemide	5.0 mg<br>
Meyprogat® 90	4 .0 mg<br>
Lactose	54.0 mg<br>
Corn starch	36.2 mg<br>
Magnesium stearate	0.3 mg<br>
Aerosil® 200	0.5 mg<br>
Example 7: 5 mg tablets of torasemide with Meyprogat® and<br>
a total weight of 85 mg<br>
Torasemide	5.0 mg<br>
Meyprogat® 90	3.4 mg<br>
Corn starch	30.77 mg<br>
Aerosil® 200	0.42 mg<br>
Magnesium stearate	0.25 mg<br>
Lactose	45.16 mg<br><br>
Example 8: 10 mg tablets of torasemide with Meyprogat® and<br>
a total weight of 170 mg<br>
Torasemide	10.0 mg<br>
Meyprogat® 90	6.8 mg<br>
Corn starch	61.54 mg<br>
Aerosil® 200	0.85 mg<br>
Magnesium stearate	0.51 mg<br>
Lactose	90.30 mg<br>
Example 9: 20 mg tablets of torasemide with Meyprogat® and<br>
a total weight of 340 mg<br>
Torasemide	20.0 mg<br>
Meyprogat® 90	13.6 mg<br>
Corn starch	123.08 mg<br>
Aerosil® 200	1.70 mg<br>
Magnesium stearate	1.02 mg<br>
Lactose	180.6 mg<br>
Example 10: Pharmacokinetics of torasemide in man<br>
A randomized clinical trial was performed in a group of<br>
10 healthy volunteers who were cross-administered with a<br>
10 mg prolonged-release tablet of torasemide and a 10 mg<br>
immediate-release commercial tablet of torasemide<br>
(Sutril®, Novag, Spain). There was 1-week interval between<br>
the administration of each tablet. The prolonged-release<br>
torasemide composition exhibited a lower peak of plasma<br>
levels (Cmax) attained less acutely (tmax) with steadier<br>
levels and fewer fluctuations (Fig. 3) . The prolonged-<br>
release composition produced a lesser frequency of acute<br>
diuresis episodes than the immediate-release composition<br>
(Fig. 4).<br><br>
These data show that the compositions of torasemide in<br>
the present invention produce a lower peak of plasma<br>
levels and fewer fluctuations than the immediate-release<br>
composition. In addition, there is a shorter number of<br>
urinary urgency episodes after the prolonged-release<br>
torasemide composition.<br><br><br>
Experimental Data on kinetic profiles of torasemide formulations (tablets) of the<br>
invention<br>
Meyprogat® 90 (i.e. guar gum) at 10%, 5% and 3% of the total tablet weight was tested as<br>
shown in Table below for the 5 mg tablet dose (5 mg torasemide).<br><br>
The following dissolution tests were performed with hydrochloric acid 0.1 N.<br>
In comparison with Sutril® (Immediate release formulation) experimental tablets showed<br>
a prolonged release behaviour starting from 3% of guar gum (batch T1804). The total<br>
release of the active in this batch (T1804) was produced in 5 hours. Batches with 5% and<br>
10% of the excipient (T1704 and T1604) presented a 75% active release within 5 hours<br>
with a similar kinetic profile. The following table and figure show the results of the<br>
kinetic profile of these formulations.<br><br>
Table. Release values (with HC1 0.1N) for tablets manufactured with Meyprogat® 90.<br><br>
Figure.5 - Release profiles (with HC1 0.1N) of Torasemide from Meyprogat® 90 matrix<br>
tablets.<br>
The percentage of lactose in the experiments is above 45% with respect of the blend. The<br>
amount of guar gum is in the range of 1 to 20%.<br>
Clearly, the specific combination of elements in the formulations, and their<br>
concentrations provide a surprising effect on release rate compared to an immediate<br>
release composition (Sutril®).<br><br>
WE CLAIM :<br>
1)	Prolonged-release compositions containing torasemide as active<br>
ingredient, a matrix-forming polymer, and lactose as diluent,<br>
wherein:<br>
a)	the torasemide is present in a proportion of from 0.5 to 20% by<br>
weight; and<br>
b)	the matrix-forming polymer is guar gum in a proportion of from 1%<br>
to 40% by weight.<br><br>
2)	Prolonged-release compositions as claimed in claim 1, wherein said<br>
compositions are tablets for oral administration.<br>
3)	Prolonged-release compositions as claimed in claim 1 or 2, wherein<br>
the matrix-forming polymer further comprises one or more of the<br>
group of polymers consisting of acrylic acid, cellulose, glycerol<br>
behenate, xanthan gum, chitosan, gelatin, polyvinyl alcohol, and<br>
mixtures thereof.<br>
4)	Prolonged-release compositions as claimed in claim 3, wherein the<br>
acrylic matrix-forming polymer is an acrylic acid polymer.<br>
5)	Prolonged-release compositions as claimed in claim 3, wherein the<br>
cellulose matrix-forming polymer is selected from the group<br>
consisting of hydroxypropylmethylcellulose, methylcellulose,<br>
carboxymethylcellulose, hydroxyethylcellulose, and their<br>
pharmaceutically acceptable salts, and mixtures thereof.<br>
6)	Prolonged-release compositions according to any one of claims 1-5,<br>
wherein torasemide is present in a proportion from 4 to 10%.<br>
7)	Prolonged-release compositions as claimed in any one of claims 1-6,<br>
wherein the matrix-forming polymers are present in a proportion from<br>
2 to 40%.<br><br>
8)	Prolonged-release compositions as claimed in any one of preceding<br>
claims comprising in addition one or more excipients selected from<br>
the group consisting of diluents, binders, disintegrants, and<br>
lubricants.<br>
9)	Prolonged-release compositions as claimed in claim 8, wherein, the<br>
diluents are selected from the group consisting of celluloses,<br>
mannitol, calcium phosphate, and the mixtures thereof.<br>
10)Prolonged-release compositions as claimed in claim 8, wherein, the<br>
binders are selected from the group consisting of Aerosil® 200,<br>
starch, and mixtures thereof.<br>
11)Prolonged-release compositions as claimed in claim 8, wherein, the<br>
disintegrants are selected from the group consisting of Aerosil©<br>
200, starch, and mixtures thereof.<br>
12) Prolonged-release compositions as claimed in claim 8, wherein,<br>
the lubricants are selected from the group consisting of magnesium<br>
stearate, talc, and mixtures thereof.<br><br><br><br>
ABSTRACT<br><br><br>
PROLONGED-RELEASE COMPOSITIONS COMPRISING<br>
TORASEMIDE AND A MATRIX-FORMING POLYMER<br>
The invention discloses a Prolonged-release composition comprising torasemide as<br>
active ingredient, a matrix-forming polymer, wherein the matrix forming polymer is<br>
guar gum and is present in a proportion of from 1 to 40% of said composition, and<br>
lactose as a diluent.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBhYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBjbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBjb3JyZXNwb25kZW5jZSBvdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBkZXNjcmlwdGlvbiAoY29tcGxldGUpLnBkZg==" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 description (complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBkcmF3aW5ncy5wZGY=" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBmb3JtLTEucGRm" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 form-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBmb3JtLTMucGRm" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 form-3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBmb3JtLTUucGRm" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 form-5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBnLnAuYS5wZGY=" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 g.p.a.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBpbnRlcm5hdGlvbmFsIHB1YmxpY2F0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBpbnRlcm5hdGlvbmFsIHNlYXJjaCByZXBvcnQucGRm" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 international search report.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBwY3Qgb3RoZXJzLnBkZg==" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 pct others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNiBwcmlvcml0eSBkb2N1bWVudC5wZGY=" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006 priority document.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNi1hc3NpZ25tZW50LnBkZg==" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006-assignment.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNi1jb3JyZXNwb25kZW5jZSBvdGhlcnMtMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006-correspondence others-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDI4MDgta29sbnAtMjAwNi1mb3JtLTMtMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">02808-kolnp-2006-form-3-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LSgwMy0wNy0yMDEzKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-(03-07-2013)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUFCU1RSQUNUIDEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-ABSTRACT 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUFNQU5ERUQgUEFHRVMgT0YgU1BFQ0lGSUNBVElPTi5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-AMANDED PAGES OF SPECIFICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUFTU0lHTk1FTlQucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-ASSIGNMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUNBTkNFTExFRCBQQUdFUy5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-CANCELLED PAGES.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUNMQUlNUy5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUNPUlJFU1BPTkRFTkNFLnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LURFU0NSSVBUSU9OIChDT01QTEVURSkgMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-DESCRIPTION (COMPLETE) 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LURSQVdJTkdTIDEuMS5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-DRAWINGS 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUVOR0xJU0ggVFJBTlNMQVRJT04ucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-ENGLISH TRANSLATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUVYQU1JTkFUSU9OIFJFUE9SVCBSRVBMWSBSRUNJRVZFRC5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-EXAMINATION REPORT REPLY RECIEVED.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUZPUk0gMSAxLjEucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-FORM 1 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUZPUk0gMTMucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-FORM 13.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1rb2xucC0yMDA2LWZvcm0gMTgucGRm" target="_blank" style="word-wrap:break-word;">2808-kolnp-2006-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUZPUk0gMi5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUZPUk0gMyAxLjEucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-FORM 3 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdQQS5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GPA.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtQUJTVFJBQ1QucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtQ0xBSU1TLnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtREVTQ1JJUFRJT04ucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-DESCRIPTION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtRFJBV0lOR1MucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-DRAWINGS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtRk9STSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtRk9STSAyLnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtRk9STSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtRk9STSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUdSQU5URUQtU1BFQ0lGSUNBVElPTi1DT01QTEVURS5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-GRANTED-SPECIFICATION-COMPLETE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUlOVEVSTkFUSU9OQUwgUFVCTElDQVRJT04ucGRm" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-INTERNATIONAL PUBLICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LUlOVEVSTkFUSU9OQUwgU0VBUkNIIFJFUE9SVCAmIE9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-INTERNATIONAL SEARCH REPORT &amp; OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LU9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LVBFVElUSU9OIFVOREVSIFJVTEUgMTM3LnBkZg==" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-REPLY TO EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MjgwOC1LT0xOUC0yMDA2LVRSQU5TTEFURUQgQ09QWSBPRiBQUklPUklUWSBET0NVTUVOVC5wZGY=" target="_blank" style="word-wrap:break-word;">2808-KOLNP-2006-TRANSLATED COPY OF PRIORITY DOCUMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=YWJzdHJhY3QtMDI4MDgta29sbnAtMjAwNi5qcGc=" target="_blank" style="word-wrap:break-word;">abstract-02808-kolnp-2006.jpg</a></p>
		<br>
		<div class="pull-left">
			<a href="257322-moulding-process.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="257324-an-apparatus-for-carrying-out-a-working-operation-on-a-packaging-laminate.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>257323</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>2808/KOLNP/2006</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>39/2013</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>27-Sep-2013</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>24-Sep-2013</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>26-Sep-2006</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>FERRER INTERNACIONAL,S.A</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>GRAN VIA CARLOS III,94,E-08028 BARCELONA</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>ROMERO,ALFONSO</td>
											<td>AV.PRINCEP D&#x27;ASTURIES 14,E-08012 BARCELONA</td>
										</tr>
										<tr>
											<td>2</td>
											<td>GUGLIETTA,ANTONIO</td>
											<td>MAGDALENA CORCOLL,16,.08750 MOLINS DE REI,BARCELONA</td>
										</tr>
										<tr>
											<td>3</td>
											<td>GUERRERO,MARTA</td>
											<td>TRAVESSERA DE DALT,73.E-08024 BARCELONA</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 9/20</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP2005/051340</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2005-03-23</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>P200400740</td>
									<td>2004-03-25</td>
								    <td>Spain</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/257323-prolonged-release-compositions-comprising-torasemide-and-a-matrix-forming-polymer by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 08:34:59 GMT -->
</html>
